The global Epilepsy Market is on a trajectory of significant growth, with projections indicating a rise from USD 5.33 billion in 2024 to nearly USD 9.5 billion by 2035. This expansion is underpinned by a compound annual growth rate (CAGR) of 5.39%, reflecting growing demand for advanced treatments and personalized patient care. As epilepsy affects approximately 50 million people worldwide, the...

In the evolving landscape of the China epilepsy market, the emphasis on innovative treatments is becoming more pronounced. With a market size expected to expand to USD 570 million by 2035, the anticipated CAGR of 5.39% highlights a growing public health concern. This growth is not merely a reflection of the increasing number of epilepsy cases but is also driven by the advancements in technology...